COLTENE Holding AG (SWX:CLTN)
Switzerland · Delayed Price · Currency is CHF 55.10
-0.80 (-1.43%)
Jan 30, 2026, 5:30 PM CET
COLTENE Holding AG Market Cap
COLTENE Holding AG has a market cap or net worth of 329.24 million as of January 30, 2026. Its market cap has increased by 6.78% in one year.
Market Cap
329.24M
Enterprise Value
363.80M
Revenue
240.71M
Ranking
n/a
PE Ratio
23.04
Stock Price
55.10
Market Cap Chart
Since June 23, 2006, COLTENE Holding AG's market cap has decreased from 435.24M to 329.24M, a decrease of -24.35%. That is a compound annual growth rate of -1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 329.24M | 2.61% |
| Dec 30, 2025 | 320.88M | 4.48% |
| Dec 30, 2024 | 307.13M | -28.21% |
| Dec 29, 2023 | 427.85M | -6.04% |
| Dec 30, 2022 | 455.33M | -32.21% |
| Dec 30, 2021 | 671.65M | 30.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 288.96B |
| Novartis AG | 219.28B |
| Lonza Group AG | 37.50B |
| Galderma Group AG | 33.93B |
| Basilea Pharmaceutica AG | 674.62M |
| Newron Pharmaceuticals | 405.30M |
| IVF Hartmann Holding AG | 345.30M |
| DocMorris AG | 289.89M |